Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

November 17, 2022

https://www.globenewswire.com/news-release/2022/11/17/2558182/0/en/Organigram-and-Intercure-dba-Canndoc-Sign-New-International-Strategic-Agreement-Representing-Largest-Such-Deal-to-Date-for-Both-Companies.html

TORONTO and HERZILA, Israel, Nov. 17, 2022 (GLOBE NEWSWIRE) — Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), ( “Organigram”), a leading Canadian licensed producer of cannabis, and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ:INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) Israel’s largest and most established pharmaceutical cannabis producer, today jointly announced that they have entered into a new multi-year agreement (the “New Strategic Agreement”) for Organigram to continue supply of dried flower to InterCure.

Read more at globenewswire.com

Related news for (INCR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.